 The purpose of this research study is to determine the safest and most effective dose of 5-FU that can be given with docetaxel Taxotere, Cisplatin and cetuximab to patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck. We will also be studying the toxicity of this regimen of 4 drugs and the tumor response. 